立即開始
Softclick-Capital

Genmap Correction -40 %

看多
Genmab A/S (NASDAQ:GMAB)  
Softclick-Capital  
NASDAQ:GMAB   Genmab A/S
Trend Analysis genmab biotech crash
1
2
trendanalysis genmab biotech crash
I like Genmab. The stock was one of my long positions for many years. I went into cash in the fall of 2021. After minus 40 percent, I will now gradually add to Genmab again.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。